Monoclonal antibody-induced papulopustular rash: Clinical course, communication to health-care professionals and reactive measures as reported by patients-Reference-Cited by-同舟云学术

Monoclonal antibody-induced papulopustular rash: Clinical course, communication to health-care professionals and reactive measures as reported by patients

Published:2016-02 Issue: Volume:20 Page:133-139
ISSN:1462-3889
Container-title:European Journal of Oncology Nursing
language:en
Short-container-title:European Journal of Oncology Nursing

Author:

Cignola Sara,Gonella Silvia,Alessandra Bin,Palese Alvisa

Publisher

Elsevier BV

Subject

Oncology(nursing),General Medicine

Reference47 articles.

1. Toxicity associated with combination oxaliplatin plus fluoropyrimidine with or without cetuximab in the MRC COIN trial experience;Adams;Br. J. Cancer,2009

2. Recommendations on management of EGFR inhibito-induced skin toxicity: a systematic review;Baas;Cancer Treat. Rev.,2012

3. Folliculitis induced by EGFR inhibitors, preventive and curative efficacy of tetracyclines in the management and incidence rates according to the type of EGFR inhibitor administered: a systematic literature review;Bachet;Oncol.,2012

4. The effect of cytotoxic chemotherapy on the risk of high-grade acneiform rash to cetuximab in cancer patients: a meta-analysis;Balagula;Ann. Oncol.,2011

5. Phase II Multicenter Study of the Antiepidermal Growth Factor Receptor Monoclonal Antibody Cetuximab in Combination With Platinum-Based Chemotherapy in Patients With Platinum-Refractory Metastatic and/or Recurrent Squamous Cell Carcinoma of the Head and Neck

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Dermatologic Toxicities of Anticancer Therapy;Abeloff's Clinical Oncology;2020